Compare JAYS.DYESTUF with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JAYS.DYESTUF vs GENERIC PHARMASEC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JAYS.DYESTUF GENERIC PHARMASEC JAYS.DYESTUF/
GENERIC PHARMASEC
 
P/E (TTM) x 13.8 112.3 12.3% View Chart
P/BV x 0.8 11.2 7.5% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 JAYS.DYESTUF   GENERIC PHARMASEC
EQUITY SHARE DATA
    JAYS.DYESTUF
Mar-21
GENERIC PHARMASEC
Mar-21
JAYS.DYESTUF/
GENERIC PHARMASEC
5-Yr Chart
Click to enlarge
High Rs8017 481.1%   
Low Rs237 314.6%   
Sales per share (Unadj.) Rs146.20.8 18,991.2%  
Earnings per share (Unadj.) Rs5.20 11,436.0%  
Cash flow per share (Unadj.) Rs7.30 15,829.5%  
Dividends per share (Unadj.) Rs0.200-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs97.10.7 13,014.0%  
Shares outstanding (eoy) m8.69276.86 3.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.415.6 2.3%   
Avg P/E ratio x9.9263.5 3.8%  
P/CF ratio (eoy) x7.1260.9 2.7%  
Price / Book Value ratio x0.516.0 3.3%  
Dividend payout %3.90-   
Avg Mkt Cap Rs m4483,314 13.5%   
No. of employees `000NANA-   
Total wages/salary Rs m742 3,981.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,270213 596.1%  
Other income Rs m93 282.3%   
Total revenues Rs m1,279216 591.4%   
Gross profit Rs m7512 627.6%  
Depreciation Rs m180 14,983.3%   
Interest Rs m30-   
Profit before tax Rs m6315 415.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m183 698.8%   
Profit after tax Rs m4513 358.9%  
Gross profit margin %5.95.6 105.3%  
Effective tax rate %28.116.7 168.1%   
Net profit margin %3.65.9 60.2%  
BALANCE SHEET DATA
Current assets Rs m1,057268 394.7%   
Current liabilities Rs m30672 426.8%   
Net working cap to sales %59.292.1 64.3%  
Current ratio x3.53.7 92.5%  
Inventory Days Days15148 10.3%  
Debtors Days Days119,154,210128,898,635 92.4%  
Net fixed assets Rs m11810 1,143.7%   
Share capital Rs m9277 3.1%   
"Free" reserves Rs m835-70 -1,189.2%   
Net worth Rs m844207 408.5%   
Long term debt Rs m40-   
Total assets Rs m1,176278 422.6%  
Interest coverage x19.0NM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.10.8 141.0%   
Return on assets %4.14.5 91.5%  
Return on equity %5.36.1 87.8%  
Return on capital %7.87.3 106.9%  
Exports to sales %61.40-   
Imports to sales %11.90-   
Exports (fob) Rs m779NA-   
Imports (cif) Rs m151NA-   
Fx inflow Rs m7790-   
Fx outflow Rs m1570-   
Net fx Rs m6230-   
CASH FLOW
From Operations Rs m-6-21 29.8%  
From Investments Rs m34-14 -243.3%  
From Financial Activity Rs m3845 84.8%  
Net Cashflow Rs m6610 692.5%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 60.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.3 40.0 63.1%  
Shareholders   2,747 17,121 16.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JAYS.DYESTUF With:   ASAHI SONGWON    BODAL CHEMICALS    



Today's Market

Sensex Plunges 656 Points, Nifty Ends Below 18,000; Oil & Gas, Metal Stocks Outperform(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

Ami Organics Stock Makes Impressive Debut on Bourses. Lists at 49% Premium (Views On News)

Sep 14, 2021

Shares of Ami Organics makes a strong debut on the stock exchange. Did you bid for the IPO?

Chemplast Sanmar Makes Flat Debut as IPO Frenzy Fizzles Out (Views On News)

Aug 24, 2021

The grey market had indicated a flat listing for shares of Chemplast Sanmar ahead of its debut.

Understanding Aarti Industries' Demerger (Views On News)

Aug 20, 2021

Will the pharma unit's demerger unlock value for shareholders?

What Next for Devyani, Zomato, & Tatva Chintan Pharma After Stellar IPO Gains? (Views On News)

Aug 20, 2021

What's the outlook for Devyani, Zomato, and Tatva Chintan Pharma after robust listings?

Pidilite Results Review: Net Profit Spikes as Sales Rise 121% (Views On News)

Aug 12, 2021

Pidilite posts strong sales growth and a multi-fold jump in bottomline.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JAYS.DYESTUF SHARE PRICE


Jan 19, 2022 (Close)

TRACK JAYS.DYESTUF

  • Track your investment in JAYS.DYESTUF with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

JAYS.DYESTUF - BODAL CHEMICALS COMPARISON

COMPARE JAYS.DYESTUF WITH

MARKET STATS